SCHEMBL2568265

SCHEMBL2568265

C=CCc1ccc(C)c(OC)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.73
PPARA Q07869 3/20 0.73
PPARG P37231 1/20 0.73
PPARD Q03181 1/20 0.73
CYP3A4 P08684 4/20 0.67
ALOX5 P09917 3/20 0.67
PTGS1 P23219 2/20 0.67
AR P10275 1/20 0.67
TRPM8 Q7Z2W7 1/20 0.67
MAPT P10636 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
SMN1; SMN2 Q16637 4/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
KDM4E B2RXH2 1/20 0.56
LMNA P02545 1/20 0.56
GAA P10253 1/20 0.56
HTT P42858 1/20 0.56
GABRA1 P14867 3/20 0.55
GABRB2 P47870 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10732559 0.85 ALDH1A1 (0.73) ALDH1A1PPARAPPARGPPARDCYP3A4
Methyleugenol SCHEMBL29376951 0.85 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDCYP3A4
Methyleugenol SCHEMBL113794 0.85 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDCYP3A4
Methyleugenol SCHEMBL1869396 0.85 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDCYP3A4
SCHEMBL9615212 0.83 ALDH1A1 (0.65) ALDH1A1PPARAPPARGPPARDCYP3A4
Methyleugenol SCHEMBL27600712 0.83 ALDH1A1 (0.96) ALDH1A1PPARAPPARGPPARDCYP3A4
Methyleugenol SCHEMBL27951383 0.83 ALDH1A1 (0.96) ALDH1A1PPARAPPARGPPARDCYP3A4
Methyleugenol SCHEMBL5564539 0.83 ALDH1A1 (0.96) ALDH1A1PPARAPPARGPPARDCYP3A4
SCHEMBL16865526 0.83 ALDH1A1 (0.50) ALDH1A1PPARAPPARGPPARDCYP3A4
SCHEMBL14040620 0.82 ALDH1A1 (0.50) ALDH1A1PPARAPPARGPPARDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230232831-A1 MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2023-07-27 US disclosed
US-20230232831-A1 MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2023-07-27 US disclosed
US-20230200386-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS HERBICIDES IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2023-06-29 US disclosed
US-20230200386-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS HERBICIDES IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2023-06-29 US disclosed
US-20230207874-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME KIA CORPORATION (KR) 2023-06-29 US disclosed
US-20230207876-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME HYUNDAI MOTOR COMPANY (KR) 2023-06-29 US disclosed
US-20230189802-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS BAITS KITTRICH CORPORATION 2023-06-22 US disclosed
EP-3233798-B1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT OREAL (FR) 2019-04-10 EP disclosed
US-20180206489-A1 REPELLENT EFFECTIVE AGAINST ANOPHELES GAMBIAE SIMON FRASER UNIVERSITY (CA) 2018-07-26 US disclosed
US-20170360668-A1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT L'OREAL (FR) 2017-12-21 US disclosed
US-20160152538-A1 REPELLENT EFFECTIVE AGAINST ANOPHELES GAMBIAE SIMON FRASER UNIVERSITY (CA) 2016-06-02 US disclosed
US-20150336866-A1 SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2015-11-26 US disclosed
EP-2280051-B1 Secondary emulsifiers for inverted emulsion fluids and methods for making an using same CLEARWATER INT LLC (US) 2015-02-11 EP disclosed
US-20140364457-A1 COMPOSITIONS FOR REDUCING AB 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) KAREUS THERAPEUTICS, SA (CH) 2014-12-11 US disclosed
US-8846721-B2 Compositions for reducing aβ 42 production and their use in treating alzheimer's disease (AD) KAREUS THERAPEUTICS SA (CH) 2014-09-30 US disclosed
EP-2561051-A1 ORGANIC CARBONATES WITH VANILLA ODOR Firmenich SA (CH) 2013-02-27 EP disclosed
WO-2011132098-A1 ORGANIC CARBONATES WITH VANILLA ODOR FIRMENICH SA (CH) 2011-10-27 WO disclosed
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR SIMON FRASER UNIVERSITY (CA) 2010-11-25 US disclosed
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar SIMON FRASER UNIVERSITY (CA) 2010-07-29 US disclosed
EP-2166016-A1 Phosphoramidate Derivatives of Nucleosides Centocor Ortho Biotech Products L.P. (US) 2010-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189802-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS BAITS CYP51A1, CYP4A22, ACHE ALDH1A1 1885/4885PPARA 878/4885PPARG 760/4885
US-20150336866-A1 SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES DDT, ABL1, TYR ALDH1A1 3454/4885PPARA 646/4885PPARG 308/4885
US-20230200386-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS HERBICIDES DDT, CYP4B1, GSTO1 ALDH1A1 161/4885PPARA 156/4885PPARG 150/4885
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar L3MBTL3, L3MBTL4, L3MBTL1 ALDH1A1 4132/4885PPARA 3859/4885PPARG 4431/4885
US-20180206489-A1 REPELLENT EFFECTIVE AGAINST ANOPHELES GAMBIAE L3MBTL3, PRMT3, PRMT1 ALDH1A1 3092/4885PPARA 4002/4885PPARG 4226/4885
US-20140364457-A1 COMPOSITIONS FOR REDUCING AB 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) PSEN2, APP, PSEN1 ALDH1A1 2084/4885PPARA 2619/4885PPARG 3162/4885
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR L3MBTL3, L3MBTL4, L3MBTL1 ALDH1A1 4180/4885PPARA 3912/4885PPARG 4457/4885
US-20170360668-A1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT TPH1, TPH2, TDO2 ALDH1A1 152/4885PPARA 433/4885PPARG 1078/4885
US-20160152538-A1 REPELLENT EFFECTIVE AGAINST ANOPHELES GAMBIAE L3MBTL3, PRMT3, PRMT1 ALDH1A1 3092/4885PPARA 4002/4885PPARG 4226/4885
US-20230207874-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME TERT, AS3MT, TELO2 ALDH1A1 1010/4885PPARA 3422/4885PPARG 4109/4885
US-20230232831-A1 MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS CYP51A1, CYP17A1, CYP4A11 ALDH1A1 813/4885PPARA 144/4885PPARG 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.